Related Experiment Video
Updated: Apr 2, 2026

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
Published on: June 13, 2019
Superficial CIC::DUX4 Sarcoma With Focal WT1 Expression: Histomorphologic Clues and Immunohistochemical Pitfalls
Janice Jiang1, Brandon Say2, Ryanne Brown3
1Department of Dermatology, MetroHealth Medical Center, Case Western Reserve University, Cleveland, Ohio, USA.
Abstract:
CIC::DUX4 sarcoma (CDS) is a rare cutaneous and deep soft tissue tumor in the differential diagnosis of small round blue cell sarcomas. CDS, by definition, is negative for rearrangements in EWSR1, and has been reported to have strong nuclear WT1 expression and ETV4 expression in most published cases so far. We herein report a case of challenging CDS diagnosed by genomic profiling, with weak, focal cytoplasmic WT-1 positivity, positive staining for CD56, CD138 (subset), and CD4 (subset). This case highlights the challenges involved in evaluating cutaneous small round blue cell tumors based on morphology and immunohistochemistry alone, especially in the presence of an atypical immunophenotype.
Insights
CIC::DUX4 sarcoma (CDS) is a rare tumor. Genomic profiling aided diagnosis in a challenging case with an atypical immunophenotype, underscoring difficulties in diagnosing small round blue cell sarcomas.
Area of Science:
- Oncology
- Pathology
- Genetics
Background:
- CIC::DUX4 sarcoma (CDS) is a rare tumor.
- It is often included in the differential diagnosis of small round blue cell sarcomas.
- Typically, CDS is EWSR1-negative with strong nuclear WT1 and ETV4 expression.
Related Concept Videos
Abnormal Proliferation
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...

